GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adimmune Corp (TPE:4142) » Definitions » Accounts Receivable

Adimmune (TPE:4142) Accounts Receivable : NT$188 Mil (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Adimmune Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Adimmune's accounts receivables for the quarter that ended in Dec. 2024 was NT$188 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Adimmune's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 31.44.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Adimmune's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was NT$-0.76.


Adimmune Accounts Receivable Historical Data

The historical data trend for Adimmune's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adimmune Accounts Receivable Chart

Adimmune Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 109.74 99.64 534.35 1,308.08 187.81

Adimmune Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,308.08 402.03 353.89 698.10 187.81

Adimmune Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Adimmune Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Adimmune's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=187.806/545.069*91
=31.44

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Adimmune's accounts receivable are only considered to be worth 75% of book value:

Adimmune's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2472.127+0.75 * 187.806+0.5 * 627.993-2919.762
-0-328.97)/421.508
=-0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Adimmune Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Adimmune's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Adimmune Business Description

Traded in Other Exchanges
N/A
Address
Tanxing Road, No. 3, Sector 1, Tanzi District, Taichung, TWN, 427003
Adimmune Corp is a Taiwan-based company. It is engaged in the development, manufacture, and distribution of vaccines and other biological products. Its pipeline consists of products like AdimFlu-S (QIS) which is a vaccine intended for use in the prevention of influenza, and TetraFlu among others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the USA, China, and other regions.

Adimmune Headlines

No Headlines